Patient-reported health-related quality of life from the phase III TOURMALINE-MM1 study of ixazomib-lenalidomide-dexamethasone versus placebo-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Patient-reported health-related quality of life from the phase III TOURMALINE-MM1 study of ixazomib-lenalidomide-dexamethasone versus placebo-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF HEMATOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-05-04
DOI
10.1002/ajh.25134
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The impact of disease-related symptoms and palliative care concerns on health-related quality of life in multiple myeloma: a multi-centre study
- (2016) Christina Ramsenthaler et al. BMC CANCER
- The influence of baseline characteristics and disease stage on health-related quality of life in multiple myeloma: findings from six randomized controlled trials
- (2016) Don Robinson et al. BRITISH JOURNAL OF HAEMATOLOGY
- Health-Related Quality-of-Life Results From the Open-Label, Randomized, Phase III ASPIRE Trial Evaluating Carfilzomib, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With Relapsed Multiple Myeloma
- (2016) A. Keith Stewart et al. JOURNAL OF CLINICAL ONCOLOGY
- Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
- (2016) Philippe Moreau et al. NEW ENGLAND JOURNAL OF MEDICINE
- Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma
- (2016) Meletios A. Dimopoulos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma
- (2016) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment for patients with newly diagnosed multiple myeloma in 2015
- (2015) María-Victoria Mateos et al. BLOOD REVIEWS
- Pomalidomide and Low-Dose Dexamethasone Improves Health-Related Quality of Life and Prolongs Time to Worsening in Relapsed/Refractory Patients With Multiple Myeloma Enrolled in the MM-003 Randomized Phase III Trial
- (2015) Katja Weisel et al. Clinical Lymphoma Myeloma & Leukemia
- Health-related quality-of-life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide
- (2015) M. Delforge et al. HAEMATOLOGICA
- Continuous Therapy Versus Fixed Duration of Therapy in Patients With Newly Diagnosed Multiple Myeloma
- (2015) Antonio Palumbo et al. JOURNAL OF CLINICAL ONCOLOGY
- “Real world” outcome of lenalidomide plus dexamethasone in the setting of recurrent and refractory multiple myeloma: Extended follow-up of a retrospective multicenter study by the “rete ematologica pugliese”
- (2015) G. Mele et al. LEUKEMIA RESEARCH
- Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma
- (2015) Sagar Lonial et al. NEW ENGLAND JOURNAL OF MEDICINE
- Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma
- (2015) A. Keith Stewart et al. NEW ENGLAND JOURNAL OF MEDICINE
- Optimizing quality of life in multiple myeloma patients: current options, challenges and recommendations
- (2015) Helena Maes et al. Expert Review of Hematology
- Health-related quality-of-life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide
- (2015) M. Delforge et al. HAEMATOLOGICA
- Understanding what matters most to people with multiple myeloma: a qualitative study of views on quality of life
- (2014) Thomas R Osborne et al. BMC CANCER
- Health-related quality of life from the MM-003 trial of pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed and/or refractory multiple myeloma
- (2014) K. W. Song et al. HAEMATOLOGICA
- Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma
- (2014) Lotfi Benboubker et al. NEW ENGLAND JOURNAL OF MEDICINE
- “Real-world” data on the efficacy and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma who were treated according to the standard clinical practice: a study of the Greek Myeloma Study Group
- (2013) Eirini Katodritou et al. ANNALS OF HEMATOLOGY
- Efficacy and safety profile of long-term exposure to lenalidomide in patients with recurrent multiple myeloma
- (2013) Guillemette Fouquet et al. CANCER
- Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients
- (2013) S K Kumar et al. LEUKEMIA
- Review of health-related quality of life data in multiple myeloma patients treated with novel agents
- (2013) P Sonneveld et al. LEUKEMIA
- Memory loss during lenalidomide treatment: a report on two cases
- (2013) Adeline Rollin-Sillaire et al. BMC Pharmacology & Toxicology
- Health-related quality of life in elderly, newly diagnosed multiple myeloma patients treated with VMP vs. MP: results from the VISTA trial
- (2012) Michel Delforge et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- What issues matter most to people with multiple myeloma and how well are we measuring them? A systematic review of quality of life tools
- (2012) Thomas R. Osborne et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma
- (2012) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reasons for Rejection of Patient-Reported Outcome Label Claims: A Compilation Based on a Review of Patient-Reported Outcome Use among New Molecular Entities and Biologic License Applications, 2006–2010
- (2012) Carla DeMuro et al. VALUE IN HEALTH
- Effect of thalidomide with melphalan and prednisone on health-related quality of life (HRQoL) in elderly patients with newly diagnosed multiple myeloma: a prospective analysis in a randomized trial
- (2011) Silvia G. R. Verelst et al. ANNALS OF HEMATOLOGY
- Responsiveness and minimal important score differences in quality-of-life questionnaires: a comparison of the EORTC QLQ-C30 cancer-specific questionnaire to the generic utility questionnaires EQ-5D and 15D in patients with multiple myeloma
- (2011) Ann Kristin Kvam et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Health-related quality of life assessment in randomised controlled trials in multiple myeloma: a critical review of methodology and impact on treatment recommendations
- (2009) Ann Kristin Kvam et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Health related quality of life in a nationally representative sample of haematological patients
- (2009) Anna T. Johnsen et al. EUROPEAN JOURNAL OF HAEMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now